Recurrent fever promotes Plasmodium falciparum development in human erythrocytes

被引:68
作者
Pavithra, SR [1 ]
Banumathy, G [1 ]
Joy, O [1 ]
Singh, V [1 ]
Tatu, U [1 ]
机构
[1] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India
关键词
D O I
10.1074/jbc.M409165200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human malarial parasite Plasmodium falciparum (Pf) is exposed to wide temperature fluctuations during its life cycle, ranging from 25degreesC in the mosquito vector and 37degreesC in humans to 41degreesC during febrile episodes in the patient. The repeated occurrence of fever at regular intervals is a characteristic of human malaria. We have examined the influence of repeated exposure to elevated temperatures encountered during fever on the intra-erythrocytic development of the parasite. Using flow cytometry, we show that repeated exposure to temperatures mimicking febrile episodes promotes parasite development in human erythrocytes. Heat shock-mediated cytoprotection and growth promotion is dependent on the heat shock protein 90 (PfHsp90) multi-chaperone complex. Inhibition of PfHsp90 function using geldanamycin attenuates temperature-dependent progression from the ring to the trophozoite stage. Geldanamycin inhibits parasite development by disrupting the PfHsp90 complex consisting of PfHsp70, PfPP5, and tubulin, among other proteins. While explaining the contribution of febrile episodes to the pathogenesis of malaria, our results implicate temperature as an important environmental cue used by the parasite to coordinate its development in humans.
引用
收藏
页码:46692 / 46699
页数:8
相关论文
共 29 条
[1]   A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages [J].
Bannister, LH ;
Hopkins, JM ;
Fowler, RE ;
Krishna, S ;
Mitchell, GH .
PARASITOLOGY TODAY, 2000, 16 (10) :427-433
[2]   Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes [J].
Banumathy, G ;
Singh, V ;
Pavithra, SR ;
Tatu, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :18336-18345
[3]   Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria [J].
Brandts, CH ;
Ndjave, M ;
Graninger, W ;
Kremsner, PG .
LANCET, 1997, 350 (9079) :704-709
[4]  
BRUCECHWATT LJ, 1986, CHEMOTHERAPY MALARIA, P120
[5]   The 90-kDa molecular chaperone family:: Structure, function, and clinical applications.: A comprehensive review [J].
Csermely, P ;
Schnaider, T ;
Soti, C ;
Prohászka, Z ;
Nardai, G .
PHARMACOLOGY & THERAPEUTICS, 1998, 79 (02) :129-168
[6]   A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, Plasmodium falciparum [J].
Dobson S. ;
Kar B. ;
Kumar R. ;
Adams B. ;
Barik S. .
BMC Microbiology, 1 (1) :1-10
[7]   Genome sequence of the human malaria parasite Plasmodium falciparum [J].
Gardner, MJ ;
Hall, N ;
Fung, E ;
White, O ;
Berriman, M ;
Hyman, RW ;
Carlton, JM ;
Pain, A ;
Nelson, KE ;
Bowman, S ;
Paulsen, IT ;
James, K ;
Eisen, JA ;
Rutherford, K ;
Salzberg, SL ;
Craig, A ;
Kyes, S ;
Chan, MS ;
Nene, V ;
Shallom, SJ ;
Suh, B ;
Peterson, J ;
Angiuoli, S ;
Pertea, M ;
Allen, J ;
Selengut, J ;
Haft, D ;
Mather, MW ;
Vaidya, AB ;
Martin, DMA ;
Fairlamb, AH ;
Fraunholz, MJ ;
Roos, DS ;
Ralph, SA ;
McFadden, GI ;
Cummings, LM ;
Subramanian, GM ;
Mungall, C ;
Venter, JC ;
Carucci, DJ ;
Hoffman, SL ;
Newbold, C ;
Davis, RW ;
Fraser, CM ;
Barrell, B .
NATURE, 2002, 419 (6906) :498-511
[8]   Heat-shock protein 90 (hsp90) binds in vitro to tubulin dimer and inhibits microtubule formation [J].
Garnier, C ;
Barbier, P ;
Gilli, R ;
Lopez, C ;
Peyrot, V ;
Briand, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) :414-419
[9]   HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo [J].
Hu, YZ ;
Mivechi, NF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :17299-17306
[10]   Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells [J].
Kaiser, K ;
Camargo, N ;
Kappe, SHI .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) :1045-1050